RBM17 controls apoptosis and proliferation to promote Glioma progression
作者单位：The first affiliated hospital of wenzhou medical university
会议名称：《2018年浙江省神经外科学学术年会》
会议日期：2018年
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
摘 要：Objective The splicing factor SPF45 (RBM17) is a well-known component of the spliceosome that is involved in alternative splicing. RBM17 is frequently overexpressed in many tumors and plays a crucial role in cancer progression and drug resistance. However, the role of RBM17 in the development of glioma has not been thoroughly elucidated to date.